Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposiform hemangioendothelioma and tuftedangioma: A multicenter prospective randomized controlled clinical trial. Kaposiform haemangioendothelioma (KHE) and tuftedangioma (TA) are rare vascular tumors that can cause life-threatening Kasabach-Merritt phenomenon. No evidence-based treatment strategies have yet been
Intracranial intraaxial cerebral tuftedangioma: case report. Tuftedangioma (TA) is a rare, slow-growing, vascular lesion that commonly presents as a solitary macule, papule, or nodule arising in the soft tissues of the torso, extremities, and head and neck in children and young adults. Adult-onset cases have been infrequently reported. While typically benign, TAs may be locally aggressive
Multimodal treatment of Kasabach-Merritt syndrome arising from tuftedangioma: A case report Kasabach-Merritt syndrome (KMS) is a rare type of vascular tumor associated with a severely decreased platelet count. No standard guidelines for the treatment of the disease have been established so far. In the present study, a 1-year-old pediatric patient with KMS arising from tuftedangioma
The clinical spectrum of kaposiform hemangioendothelioma and tuftedangioma. Kasposiform hemoangioendothelioma (KHE) and tuftedangioma (TA) are classifed as vascular tumors with locally aggressive and benign growth potential, respectively, within the classification schema proposed by the International Society for the Study of Vascular Anomalies. A unique feature of these vascular tumors
TuftedAngioma of Eyelid in an Adult - A Case Report TuftedAngiomas also known as angioblastomas /Angioblastoma of Nagakawa are rare vascular neoplasms localised to the skin and subcutaneous tissues with the upper trunk and neck being most common sites. They are mainly seen in children but a few cases in juveniles and adults have been reported. We hereby report this case, a 40-year-old male who presented with a right lower lid, painless, slowly progressive, firm swelling diagnosed as TuftedAngioma on histopathology and immunohistochemistry.
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and TuftedAngioma The aim of this study was to evaluate the efficacy and safety of topical application of tacrolimus for superficial Kaposiform hemangioendothelioma (KHE) and tuftedangioma (TA). Kaposiform hemangioendothelioma (KHE) and tuftedangiomas (TA) are rare vascular tumors, which are apparent predominantly in infancy or early childhood. Currently, no standard treatment regimens exist for KHE/TA. The aim of this study was to evaluate the efficacy and safety of topical application of tacrolimus for superficial Kaposiform hemangioendothelioma (KHE) and tuftedangioma (TA).
slow flow).Vascular tumors encompass a broad range of lesions, including angiosarcomas and tuftedangiomas, among others. However, the most common vascular tumor remains the hemangioma, a benign and self-limited lesion usually found in infants.;Currently, various schemas are used to categorize vascular tumors and malformations, [4, 5] stemming from the original classification described by Mulliken and Glowacki, [3] which is based on the pathologic characteristics of the endothelium and the natural course of the lesion. A simplified outline of their original classification of vascular anomalies is as follows [6] :Vascular tumors include the following: * * Hemangioma - Congenital; infantile * * Kaposiform hemangioendothelioma * * Tuftedangioma * * Pyogenic granuloma
to several other vascular lesions (congenital hemangioma, tuftedangioma, anastomosing hemangioma, lobular capillary hemangioma, and kaposiform hemangioendothelioma) recently reported to have GNAQ, GNA11, or GNA14 mutations.